Sean Tucker - Mar 28, 2023 Form 4/A Insider Report for Vaxart, Inc. (VXRT)

Role
SVP, Chief Scientific Officer
Signature
/s/ Edward Berg, Attorney-in-Fact
Stock symbol
VXRT
Transactions as of
Mar 28, 2023
Transactions value $
$0
Form type
4/A
Date filed
4/1/2024, 07:24 PM
Date Of Original Report
Mar 20, 2024
Previous filing
Mar 21, 2023
Next filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VXRT Common Stock 360K Mar 28, 2023 Direct F1
holding VXRT Common Stock 51.5K Mar 28, 2023 By joint tenancy with Frances Chang and Sean Tucker F1
holding VXRT Common Stock 9.06K Mar 28, 2023 By Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to the Form 4 filed on March 20, 2024, is being filed to correct an administrative error in Column 5 of Table 1, which previously included in the amount of securities beneficially owned directly by the reporting person the amount of securities indirectly, beneficially owned by the reporting person through his spouse and with Frances Chang by joint tenancy.